U.S. markets closed

Endo International plc (ENDP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.23-0.28 (-3.73%)
At close: 4:00PM EST

7.20 -0.03 (-0.41%)
After hours: 4:48PM EST

Endo International plc

Minerva House
First Floor Simmonscourt Road Ballsbridge
Dublin 4
353 1 268 2000

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees3,397

Key Executives

NameTitlePayExercisedYear Born
Mr. Blaise ColemanPres, CEO & Director1.9MN/A1974
Mr. Matthew Joseph MalettaExec. VP & Chief Legal Officer1.82MN/A1972
Mr. Patrick A. BarryExec. VP & Pres of Global Commercial Operations1.47MN/A1968
Mr. Mark T. BradleyExec. VP & CFON/AN/AN/A
Mr. Robert PolkeExec. VP & Global Head of OperationsN/AN/AN/A
Mr. Jack D. BoyleSr. VP, Controller & Chief Accounting OfficerN/AN/A1976
Ms. Ruth ThorpeSr. VP of Information Technology & Chief Information OfficerN/AN/AN/A
Ms. Laure E. ParkSr. VP of Investor Relations & Corp. AffairsN/AN/AN/A
Ms. Susan WilliamsonSr. VP & Chief Compliance OfficerN/AN/AN/A
Ms. Tracy BassoChief HR OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Corporate Governance

Endo International plc’s ISS Governance QualityScore as of December 2, 2020 is 7. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 3; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.